HUTCHMED (China) Limited (ADR)
General ticker "HCM" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $3.5B (TTM average)
HUTCHMED (China) Limited (ADR) follows the US Stock Market performance with the rate: 7.3%.
Estimated limits based on current volatility of 1.5%: low 15.15$, high 15.62$
Factors to consider:
- Total employees count: 590 as of 2016
- Current price 17.9% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [17.39$, 27.85$]
- 2025-12-31 to 2026-12-31 estimated range: [19.18$, 30.18$]
Short-term HCM quotes
Long-term HCM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $838.00MM | $630.20MM | $549.96MM |
| Operating Expenses | $819.62MM | $673.91MM | $604.69MM |
| Operating Income | $18.38MM | $-43.70MM | $-54.73MM |
| Non-Operating Income | $87.23MM | $89.07MM | $577.45MM |
| Interest Expense | $0.76MM | $2.87MM | $2.87MM |
| R&D Expense | $303.06MM | $213.37MM | $164.15MM |
| Income(Loss) | $105.60MM | $45.36MM | $522.72MM |
| Taxes | $4.51MM | $7.19MM | $63.78MM |
| Profit(Loss)* | $100.78MM | $37.73MM | $458.12MM |
| Stockholders Equity | $730.54MM | $759.93MM | $1,237.93MM |
| Inventory | $50.26MM | $50.40MM | $41.13MM |
| Assets | $1,279.77MM | $1,274.20MM | $1,753.10MM |
| Operating Cash Flow | $219.26MM | $0.50MM | $-64.83MM |
| Capital expenditure | $32.61MM | $17.93MM | $14.19MM |
| Investing Cash Flow | $-291.14MM | $-96.06MM | $-29.49MM |
| Financing Cash Flow | $48.66MM | $-30.67MM | $7.86MM |
| Earnings Per Share** | $0.59 | $0.22 | $2.67 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.